Introduction
IL-4 plays a major role in stimulating B cell proliferation, alternatively spliced exon (exon 8) (9). The production of the soluble receptor by proteolysis seems to be regulated in a influencing B cell differentiation towards IgE production and different way from the mRNA form in mouse and can be participating in the T h 0/T h 2 shift of the T h cells (1-3). The IL-4 stimulated by, for example, TCR (7). A recombinant soluble signal is conferred to effector cells through binding to the IL-4 human IL-4Rα receptor form was found to either enhance receptors (IL-4R). These represent transmembrane receptors or inhibit IL-4 signaling in a dose-dependent manner in composed of a 140 kDa high-affinity binding chain supernatants of activated T cells (10), similar to previous and optionally a further IL-4Rα chain, the common γ chain findings in mouse (11). In humans, it was postulated that the shared by several IL receptors (4) or the IL-13 receptor α soluble receptor is only produced by proteolytic shedding chain (5). All chains are members of the hematopoietin (4). This is supposed to be accomplished under the control receptor superfamily (6).
of metalloproteinases (12). With respect to the numerous functions in IgE regulation, Our interest was to deduce the complete genomic structure as well as B and T cell differentiation, the IL-4Rα gene of the huIL-4Rα, including the promotor region. We investirepresents a candidate gene for atopy. Human IL-4Rα exists gated the existence of an additional form of soluble receptor in at least two forms: the membrane-bound form (huIL-4Rα) in man, produced by mRNA splicing (shuIL-4Rα/splice). and a soluble one (shuIL-4Rα). In mice two distinct pathways lead to the soluble forms. These involve alternative mRNAsplicing and limited proteolysis (shedding) of IL-4Rα (7). So Methods far, only the genomic structure of the mouse IL-4Rα gene has been described (8,9). The mRNA coding for the smaller Genomic structure soluble muIL-4Rα contains a 114 bp insert that terminates the open reading frame upstream of the predicted transmem-
The genomic organization and sequence of huIL-4Rα was brane region. Both mRNAs of the muIL-4Rα originate from derived from human chromosome 16 BAC clone CIT987SK-582J2 (NCBI HUAC004525). the same gene and the 114 bp insert corresponds to an Preparation of cDNA mRNA was isolated from human whole blood by using the RNeasy blood mini-kit (Qiagen, Hilden, Germany). The cDNA was synthesized by the First-strand cDNA synthesis kit (Amersham/Pharmacia, Freiburg, Germany). Second PCR: 5Ј-GCACCCTGAAGTCTGGGATT-3Ј and oligo (dT) primer (resulting in a DNA fragment of 302 bp in length). PCR was carried out in a volume of 10 µl containing 30 ng (150 mM sodium chloride, 3 mM potassium chloride, 1 mM cDNA, 5 pmol of each primer, 0.06 U Taq polymerase potassium dihydrogen phosphate, 7 mM disodium hydrogen (Pharmacia) and 2 mmol dNTP mix with the buffer recomphosphate and 0.05 % Tween 20) and 5% non-fat dried milk. mended by the supplier. Annealing temperatures were 35°C.
One part of the filter was incubated with monoclonal anti-STAT6 The detection of exon 8 was confirmed by sequencing and (Transduction, Lexington, KY), the appropriate horseradish comparison with the genomic sequence of huIL-4Rα. PCR peroxidase-coupled secondary antibodies (Dako, Hamburg, was performed with cDNA templates derived from whole Germany) and developed with ECL (Amersham). The other blood of probands using the primers: exon 7: 5Ј-GCACCpart of the filter was incubated with the rest of the cell extract CTGAAGTCTGGGATT-3Ј and exon 8: 5Ј-TCTCCCTCCAGAAand a 32 P-radiolabeled PCR fragment bearing the potential TGTCAGC-3Ј.
STAT6 binding site (position intron 2: 4959; primers: 5Ј-
Northern blot
CTGGCCCTTGGTGTACATTT-3Ј and 5Ј-GACACCACCTTCA-CCAAGTG-3Ј). As a negative control, the same experiment Total RNA was isolated from human whole blood by using was done using a 32 P-radiolabeled PCR fragment bearing the RNeasy blood mini-kit (Qiagen, Hilden, Germany). Then the potential STAT but not STAT6 binding site from the promotor 15 µg RNA was separated on a 1% agarose gel containing region of the gene (position -2328 of the promotor region, 2.2 M formaldehyde and afterwards transferred onto a Hybond see Fig. 2 , primers: 5Ј-GCCTGGGATGAAGCATCAAC-3Ј and N membrane (Amersham, Braunschweig, Germany). The blot 5Ј-GGCACTGACAAGTGAGCAGA-3Ј). was hybridized with a 32 P-labeled 330 bp PCR fragment coding for an extracellular part of the IL-4 receptor. Primers: 5Ј-CTTGCGAGTGGAAGATGAAT-3Ј and 5Ј-GTAATTGTCAGResults GGGGATACG-3Ј.
Genomic structure Cell culture and IL-4 stimulation for characterization of a
The genomic structure of the huIL-4Rα was found to consist STAT6 binding site of a total of 12 exons and 11 introns (Fig. 1 ). The membranebound form of huIL-4Rα is thereby coded by exons 3-7 Characterization of the STAT6 binding site followed the technique as described by Matsuno et al. (13) . Peripheral blood (extracellular domain), exon 9 (transmembrane domain) and exons 10-12 (intracellular domain). Exons 1 and 2 bear mononuclear cells were derived from whole blood and were grown for 48-72 h at 37°C and 5% CO 2 in the presence of 3 µg/ untranslated regions of the mRNA (4). Furthermore, the DNA sequence coding for a signal peptide consisting of 25 amino ml phytohemagglutinin (Gibco/BRL, Eggenstein, Germany) in RPMI 1640 containing 2 mM L-glutamine, 20 mM HEPES, 100 acids was located to exon 3. In comparison to the mouse genomic structure (9), the flanking base pair sequences of U/ml penicillin, 50 mg/ml streptomycin and 10% FCS (PAN Systems, Aidenbach, Germany).
exon-intron boundaries, the exact sizes of introns and the amino acids found at the boundaries are shown in Table 1 . Cells were made quiescent for 5-16 h in RPMI 1640/ glutamine/HEPES/penicillin/ streptomycin and 1% FCS. T cells Promotor region and transcription factors (2ϫ10 7 ) were stimulated with 100 nM human IL-4 (PAN Systems) for 5-15 min at 37°C. Cell pellets were then stored
The promotor region bears several signal sequences for transcription factors. A selection is shown in Fig. 2 . The at -80°C.
After thawing, cells were suspended in lysis buffer (10 mM existence of a STAT6 signal sequence could be verified by Southern/Western blotting analysis and was located to position Tris, pH 7.8, 5 mM EDTA, 50 mM NaCl, 30 mM pyrophosphate, 50 mM sodium fluoride, 20 µM sodium orthovanadate, 1% intron 2: 4959 (Fig. 3) . The sequence is: 5Ј-TTCTCAGGAA-3Ј. A similar potential STAT but not a STAT6 sequence from Triton X-100, 1 mM PMSF, 5 µg/ml aprotinin, 1 µg/ml pepstatin A and 10 µg/ml leupeptin; 10 8 cells/ml buffer) and incubated the promotor used as a negative control (5Ј-TTCCAGGAA-3Ј) was shown not to bind to the STAT6 proteins. for 60 min at 4°C. Insoluble material was removed by centrifugation. Part of the cell extract was separated on 12% native Differential mRNA splicing; exon 8 PAGE in several lanes and transferred onto PVDF filters (Millipore, Bedford, UK) (cell extract-blot). The residual bindBy applying PCR on cDNA derived from human whole blood cells, a short mRNA form of huIL-4Rα was detected. Sequening sites on the filters were blocked overnight with TPBS Characterization of human IL-4Rα produced by alternative splicing 1967 The number (no.) and sizes (bp or kb) are shown. The sequences at the exon-intron boundaries are described (donor and acceptor), as well as the corresponding amino acids at the boundaries.
cing and comparison to the genomic sequence revealed it to for three additional amino acids (Asn, Ile and Cys) followed by a stop codon (Fig. 4) . The existence of two distinct mRNAs be located between exon 7 and 9 (start position in intron 7: 2323). In the exon 8 sequence (195 bp) the first 9 bp code for IL-4Rα products was confirmed in Northern blotting (Fig.
Genomic structure
In general, the genomic structure of the human IL-4Rα gene resembles that of the mouse gene (9). It consists of 12 exons being interrupted by 11 introns. As the size of the mouse and human proteins slightly differ, the number of amino acids coded by the individual exons is slightly different. For example, we detected a signal peptide of 25 amino acids in human, in is bigger in size (exon 12).
signal sequence and the rest of the cell extract.
Introns
Regarding the intron sequences, they are on the whole larger than the mouse introns, so that the complete huIL-4Rα gene spans~51 kb on chromosome 16p11.2-12.1 (19), which is double in size compared to 26 kb on mouse chromosome 7.
Promotor analysis
Analyzing the promotor region, we could detect binding sites for those transcription factors having an influence on genes of the inflammatory processes (Fig. 2) . These include NFκB, Additional amino acids and the 'STOP' codon are shown in bold letters. The poly(A) tail is underlined.
AP-1, NF-AT, CREB and STAT (20)
. It may well be that huIL-4Rα is differentially controlled by these factors, which still has to be investigated. Strikingly, we could detect several potential TATA boxes in the promotor region and intron 1. There is no TATA box directly preceding the proposed cap site (mRNA start) (4) in human, whereas there is one at position -29 in mouse (9). We therefore postulate multiple transcription initiation sites in human, which have already been postulated for the muIL-4Rα gene (9).
As the mouse IL-4Rα chain is known to be up-regulated by IL-4 through STAT6 binding (21), we were interested in a potentially similar function of STAT6 in humans. By using a combined Western/Southern blot technique we could detect completely different from the mouse IL-4Rα gene, where the STAT6 binding site has been located to position -402 in the promotor and the sequence was shown to be TTCATCTGAA (21). STAT6 is an important factor for the activation of genes 5). The short mRNA form could be amplified from at least 10 belonging to the IL-4 pathway (22). There is strong evidence cDNA probes derived from whole blood of different probands.
for STAT6 not only being a direct effector substrate of the ILThe concentration of the transcripts was similar (data not 4Rα protein itself (23), but also influencing its transcription. shown).
From our findings we conclude that due to strong variations in structure from human IL-4Rα to that of the mouse, transcription is probably organized in a different way. Further studies Discussion are planned to verify this hypothesis. Association studies with common polymorphisms in the Exon 8; shuIL-4Rα produced by alternative splicing coding part of huIL-4Rα gene demonstrated a possible involvement of this gene in atopy (14-16). Functional studies
Here we present for the first time evidence for the existence of an additional exon (exon 8) being located in intron 7/8 of revealed that amino acid variants of the huIL-4Rα protein have a strong influence on the structure, and consequently huIL-4Rα. Due to the observations in the mouse system (9), exon 8 is very likely to code for a soluble form of huIL-4Rα. on substrate binding and the signaling processes of the receptor (17,18).
A corresponding mRNA coding for the soluble receptor form could be shown in Northern blotting (see Fig. 5 ). Due to the increasing importance of huIL-4Rα in the context of IgE regulation as well as its role in the T h 1/T h 2 shift and in Likewise in mice we found a stop codon in the sequence after additional amino acids. This soluble form is lacking order to allow further studies on variants in regulatory elements of the gene, the whole genomic structure has been charactertransmembrane and intracellular domains. Therefore the shorter receptor form is likely to be excreted into the cytoized in this work. 
